EDP-938, a novel nucleoprotein inhibitor of respiratory syncytial virus, demonstrates potent antiviral activities in vitro and in a non-human primate model
Rhodin et al.; PLoS Pathog. 2021 Mar 15;17(3):e1009428
Choose your Region
Please choose your region for an optimized website experience. So we can provide you with the most useful information for your country.